Toxicology
Not publishedof exam
Medicinal Chemistry
Not publishedof exam
Sterile & Nonsterile Compounding
Not publishedof exam
Pharmaceutics & Biopharmaceutics
Not publishedof exam
Pharmacognosy & Dietary Supplements
Not publishedof exam
Pharmacy Calculations & Compounding
Not publishedof exam
Clinical Pharmacogenomics
Not publishedof exam
Infection Control
Not publishedof exam
Pharmacokinetics
Not publishedof exam
Pharmaceutical Care & Disease Management
Not publishedof exam
Medication Safety
Not publishedof exam
Over-the-Counter Medication
Not publishedof exam
Pharmacy Law & Ethics
Not publishedof exam
Clinical Pharmacology & Therapeutic Decisions
Not publishedof exam
Quick Facts
- Exam
- DHA Pharmacist PHO5481
- Authority
- Dubai Health Authority
- Delivery
- Prometric CBT
- Format
- Multiple-choice questions
- Questions
- 150 questions
- Duration
- 3 hours
- Pass Score
- 60%
- Assessment Fee
- USD 240
- Result
- Pass/Fail; score withheld
- Coverage Areas
- 14 published topics
- Domain Weights
- Not published
- Attempt Limit
- Three across UAE authorities
- Retake Wait
- No DHA grace period
- Licensing Portal
- Sheryan
Poisoning Response Picker
- Patient unstable→ABCs first(Activate emergency response)
- Exposure suspected→Toxicology guidance(Contact local service)
- History available→Agent-dose-time(Include formulation)
- Initial assessment→Vitals, ECG, glucose(Check temperature)
- Unknown ingestion→Supportive care(Avoid blind antidotes)
- Decontamination considered→Toxicology protocol(Never induce emesis)
- Specific indication→Appropriate antidote(Check contraindications)
- Symptoms improve→Continue monitoring(Watch delayed toxicity)
Antidote Map
- Paracetamol
- N-acetylcysteine
- Opioids
- Naloxone
- Organophosphates
- Atropine + pralidoxime
- TCA cardiotoxicity
- Sodium bicarbonate
- Methanol/ethylene glycol
- Fomepizole
- Iron
- Deferoxamine
- Digoxin
- Digoxin immune Fab
- Heparin
- Protamine sulfate
- Warfarin
- Vitamin K; PCC for emergencies
- Methemoglobinemia
- Methylene blue; check G6PD
Toxidromes & First Response
- Opioid toxidrome
- Miosis, respiratory depression, coma
- Anticholinergic
- Hot, dry, dilated, delirious
- Cholinergic
- Secretions, bradycardia, bronchospasm
- Sympathomimetic
- Agitation, diaphoresis, tachycardia
- Serotonin syndrome
- Clonus, hyperreflexia, hyperthermia
- Neuroleptic malignant syndrome
- Rigidity, hyporeflexia, hyperthermia
- First priority
- ABCs and emergency support
- Activated charcoal
- Selected early ingestions
- Induced emesis
- Never routine
- Poison guidance
- Contact local toxicology service
Structure-Activity Clues
- pKa
- Ionization depends on environmental pH
- Unionized drug
- Crosses lipid membranes more readily
- Lipophilicity
- Often increases membrane penetration
- Beta-lactam ring
- Binds PBPs; blocks cross-linking
- Sulfonamides
- PABA pathway antagonists
- Fluoroquinolones
- Inhibit gyrase/topoisomerase IV
- Macrolides
- Bind bacterial 50S ribosome
- Aminoglycosides
- Bind bacterial 30S ribosome
- Stereoisomers
- Configuration may change activity
- Prodrug
- Activation creates active moiety
Sterile vs Nonsterile Compounding
Sterile
- Aseptic environment required
- Critical sites protected
Nonsterile
- Clean technique required
- Uniformity remains essential
Route drives sterility need
Compounding Essentials
- Aseptic technique
- Prevents microbial contamination
- Critical site
- Never touch or obstruct
- HEPA filter
- Removes airborne particles
- Unidirectional airflow
- Sweeps contaminants away
- LAFW
- Nonhazardous product protection
- BSC
- Hazardous sterile product containment
- Geometric dilution
- Incrementally mixes unequal amounts
- Levigation
- Smooths powder with liquid
- Trituration
- Grinds and mixes powders
- Aliquot method
- Measures tiny quantities indirectly
- Eutectic pair
- May liquefy when mixed
- Final label
- Strength, route, storage, BUD
Pharmaceutics Essentials
- BCS Class I
- High solubility, high permeability
- BCS Class II
- Low solubility, high permeability
- BCS Class III
- High solubility, low permeability
- BCS Class IV
- Low solubility, low permeability
- Smaller particles
- Usually dissolve faster
- Higher surface area
- Usually accelerates dissolution
- Enteric coating
- Delays release until intestine
- Modified release
- Avoid crushing unless approved
- Suspension
- Shake before measuring
- Emulsion
- Two immiscible liquid phases
- Surfactant
- Lowers interfacial tension
- First-pass effect
- Lowers systemic bioavailability
Supplement Interaction Flags
- St John's wort
- Induces CYP3A4 and P-gp
- Ginkgo
- May increase bleeding
- Garlic supplements
- May increase bleeding
- Ginseng
- May lower glucose
- Licorice
- May raise BP, lower potassium
- Kava
- Hepatotoxicity and sedation concern
- Valerian
- May add sedation
- Grapefruit
- Inhibits intestinal CYP3A4
- Natural label
- Does not guarantee safety
- Supplement history
- Ask product, dose, frequency
- Interaction action
- Check before recommending
- Pregnancy
- Avoid unverified herbal products
Calculation Safety
Units first, estimate, calculate, verify
Calculation Picker
- Need dose volume→Dose / concentration(Align units first)
- Need dilution volume→C1V1 = C2V2(Same concentration units)
- Weight-based order→mg/kg × kg(Check dose maximum)
- BSA-based order→mg/m² × BSA(Verify BSA units)
- Pump infusion→mL / hours(Convert time first)
- Gravity infusion→Drops/min formula(Use tubing factor)
- Need rapid target→Loading dose(Driven by Vd)
- Need ongoing exposure→Maintenance dose(Driven by clearance)
Calculation Formulae
- Dose volume
- Ordered dose / concentration
- C1V1 = C2V2
- Dilution equation
- % w/v
- Grams per 100 mL
- % v/v
- Milliliters per 100 mL
- 1:x w/v
- One gram per x mL
- mg/kg dose
- Dose factor × weight
- BSA dose
- mg/m² × BSA
- Infusion rate
- Volume / hours
- Drops/min
- Volume × drop factor / minutes
- Quantity dispensed
- Dose × frequency × days
- Loading dose
- Target concentration × Vd / F
- Maintenance rate
- Target concentration × clearance / F
- Cockcroft-Gault
- (140−age) × kg / (72 × SCr)
- Female CG factor
- Multiply estimate by 0.85
- Dimensional analysis
- Cancel units before calculating
- Final check
- Units, plausibility, rounding
Gene-Drug Pairs
- CYP2C19 poor metabolizer
- Reduced clopidogrel activation
- HLA-B*57:01
- Abacavir hypersensitivity risk
- HLA-B*15:02
- Carbamazepine SJS/TEN risk
- TPMT/NUDT15
- Thiopurine myelotoxicity risk
- DPYD variant
- Fluoropyrimidine toxicity risk
- UGT1A1 reduced function
- Irinotecan toxicity risk
- CYP2D6 ultrarapid
- Codeine toxicity risk
- CYP2D6 poor
- Reduced codeine activation
- SLCO1B1 variant
- Statin myopathy risk
- VKORC1/CYP2C9
- Warfarin dose sensitivity
- Genotype result
- Interpret with phenotype
- Clinical action
- Follow current prescribing guidance
Infection Control Essentials
- Before aseptic task
- Perform hand hygiene
- Visible soil
- Use soap and water
- Clean hands
- Alcohol rub often preferred
- Gloves
- Never replace hand hygiene
- Preparation area
- Keep designated and clean
- Single-dose vial
- One patient only
- Needle and syringe
- One patient, one use
- Every vial entry
- Use new needle and syringe
- Vial septum
- Disinfect before entry
- Multidose vial
- Dedicate when possible
- Used sharps
- Discard immediately
- Insulin pen
- One patient only
ADME
Absorb, distribute, metabolize, eliminate
Loading vs Maintenance Dose
Loading
- Reaches target quickly
- Driven mainly by Vd
Maintenance
- Replaces eliminated drug
- Driven mainly by clearance
Vd loads; clearance maintains
Pharmacokinetic Core
- Absorption
- Entry into systemic circulation
- Bioavailability F
- Systemically available fraction
- Vd
- Amount in body / concentration
- Clearance
- Elimination rate / concentration
- Half-life
- 0.693 × Vd / clearance
- Steady state
- Usually four to five half-lives
- Loading dose driver
- Volume of distribution
- Maintenance dose driver
- Clearance
- First-order elimination
- Constant fraction per time
- Zero-order elimination
- Constant amount per time
- Enzyme induction
- Often lowers substrate exposure
- Enzyme inhibition
- Often raises substrate exposure
- Renal impairment
- Often reduces drug clearance
PK Dose Drivers
Volume loads; clearance maintains
First-Order vs Zero-Order
First-Order
- Constant fraction eliminated
- Half-life usually constant
Zero-Order
- Constant amount eliminated
- Pathway capacity saturated
Fraction versus amount
IESA Medication Review
Indication, effectiveness, safety, adherence
Pharmaceutical Care Review
- Unnecessary therapy
- No valid indication
- Additional therapy
- Untreated condition or prevention
- Ineffective therapy
- Wrong medicine or formulation
- Dose too low
- Insufficient exposure or frequency
- Adverse reaction
- Medicine causes harmful response
- Dose too high
- Excess exposure or frequency
- Nonadherence
- Regimen not followed
- Interaction screen
- Drug, food, disease
- Renal function
- Adjust medicine and interval
- Treatment goal
- Define measurable patient outcome
- Teach-back
- Confirms patient understanding
- Follow-up
- Reassess outcome and safety
Five Rights
Patient, drug, dose, route, time
Allergy vs Side Effect
Allergy
- Immune-mediated reaction
- May preclude re-exposure
Side Effect
- Known pharmacologic effect
- May be manageable
Document reaction details
Medication Error Response
- Error intercepted→Stop process(Prevent administration)
- Exposure possible→Assess patient(Stabilize first)
- Harm suspected→Escalate immediately(Follow emergency protocol)
- Treatment needed→Notify prescriber(Use verified facts)
- Patient affected→Follow disclosure policy(Communicate transparently)
- Immediate risk controlled→Report event(Include near misses)
- Record required→Document objectively(Avoid blame)
- Review completed→Add system control(Prevent recurrence)
Medication Safety Controls
- Right patient
- Use two identifiers
- Right drug
- Verify product and label
- Right dose
- Calculate and range-check
- Right route
- Verify form and compatibility
- Right time
- Check schedule and interactions
- Allergy check
- Verify before dispensing
- Reconciliation
- Compare complete medication lists
- High-alert medicine
- Use independent double-check
- Look-alike names
- Separate and use Tall Man
- Leading zero
- Write 0.5 mg
- Trailing zero
- Never write 5.0 mg
- Oral liquid
- Use oral syringe
- Near miss
- Report and analyze
- Barcode
- Does not replace vigilance
- Medication error
- Protect patient first
Medication Error vs Adverse Reaction
Medication Error
- Preventable process failure
- May cause no harm
Adverse Reaction
- Harmful medicine response
- May occur correctly used
Classify before reporting
WWHAM Self-Care
Who, what, how long, actions, medicines
OTC Triage Picker
- Emergency symptoms→Emergency pathway(Do not delay)
- Serious red flag→Urgent referral(Avoid masking symptoms)
- Pregnant or breastfeeding→Verify safety(Consider trimester)
- Very young child→Age-specific pathway(Check local limits)
- Major comorbidity→Interaction check(Renal, hepatic, cardiac)
- Duplicate ingredients→Simplify product(Prevent overdose)
- Mild self-limited problem→Short self-care trial(Give stop rules)
- Persistent or worsening→Clinical referral(Reassess diagnosis)
OTC Referral Flags
- Chest pain
- Emergency evaluation
- Severe dyspnea
- Emergency evaluation
- Anaphylaxis signs
- Emergency treatment
- GI bleeding signs
- Urgent referral
- Severe dehydration
- Urgent referral
- Young infant fever
- Follow urgent local pathway
- Pregnancy/lactation
- Verify product safety
- Renal/hepatic disease
- Check before self-care
- Persistent symptoms
- Refer for assessment
- Worsening symptoms
- Stop self-care; refer
- Oral decongestant
- Caution uncontrolled hypertension
- NSAID
- Check GI, renal, bleeding risks
- Combination product
- Check duplicate ingredients
- Self-care advice
- Give duration and stop rules
Pharmacist vs Clinical Pharmacy
Pharmacist
- Code PHO5481
- Pass score 60%
- This sheet's target
Clinical Pharmacy
- Code PHO5482
- Pass score 70%
- Separate DHA assessment
Match title and code
DHA Licensing Path
- Starting application→Self-Assessment Tool(Check PQR eligibility)
- Credentials accepted→Primary source verification(DataFlow process)
- CBT required→Prometric assessment(Use eligibility ID)
- Requirements completed→Get Registered(DHA reviews application)
- Registration issued→Find licensed facility(Cannot practice yet)
- Facility hires→Activate license(Facility completes activation)
- License active→Practice within scope(Follow DHA requirements)
- Expiry approaches→Renew timely(Maintain requirements)
UAE Law & Ethics
- Dubai regulator
- Dubai Health Authority
- Practice permission
- Active professional license
- Registration
- Eligibility before license activation
- License activation
- Completed by hiring facility
- Professional scope
- Stay within licensed activity
- Confidentiality
- Protect patient information
- Professional duty
- Accuracy, honesty, patient welfare
- Controlled possession
- Requires legal authorization
- Controlled dispensing
- Only legally permitted cases
- Controlled prescription
- Record on national platform
- Federal law text
- Original Arabic controls
- Local procedure
- Follow authority and facility rules
Registration vs Active License
Registration
- Confirms title eligibility
- Precedes facility activation
Active License
- Permits professional practice
- Activated by hiring facility
Registration alone forbids practice
Prescription vs Controlled Medicine
Prescription Medicine
- Requires valid prescription
- Standard records apply
Controlled Medicine
- Additional legal restrictions
- National tracking applies
Controlled rules are stricter
Potency vs Efficacy
Potency
- Dose needed
- Reflected by EC50
Efficacy
- Maximum effect
- Reflected by Emax
More potent is not stronger
Interaction Checker
- Two agents flagged→Identify perpetrator(And affected substrate)
- Concentration changes→PK mechanism(ADME interaction)
- Effects combine→PD mechanism(Bleeding, sedation, QT)
- Timing may help→Separate administration(Only when evidence supports)
- Patient risk high→Avoid combination(Choose alternative)
- Combination necessary→Monitor or adjust(Define measurable endpoint)
- Plan selected→Counsel patient(Give warning signs)
- Action completed→Document rationale(Arrange follow-up)
Pharmacodynamics Core
- Agonist
- Activates receptor response
- Antagonist
- Blocks receptor activation
- Partial agonist
- Lower maximal receptor response
- Potency
- Dose needed for effect
- Efficacy
- Maximum achievable effect
- Affinity
- Binding strength at receptor
- EC50
- Concentration producing half-maximal effect
- Competitive antagonist
- Shifts dose-response right
- Noncompetitive antagonist
- Lowers maximal effect
- Therapeutic index
- Toxic dose / effective dose
- Additive effect
- Combined effects sum
- Synergistic effect
- Combined effect exceeds sum
- Tolerance
- Response decreases over time
- Tachyphylaxis
- Rapidly developing tolerance
Bactericidal vs Bacteriostatic
Bactericidal
- Kills susceptible bacteria
- Clinical effect remains context-dependent
Bacteriostatic
- Inhibits bacterial growth
- Host defenses aid clearance
Label alone never chooses therapy
Clinical Therapy Alerts
- ACE inhibitor
- Cough, hyperkalemia, angioedema
- ACEI pregnancy
- Contraindicated
- Beta blocker
- Bradycardia; masks hypoglycemia
- Loop diuretic
- Hypokalemia and volume depletion
- Spironolactone
- Hyperkalemia risk
- NSAID
- GI, renal, fluid risks
- Statin
- Myopathy and interaction check
- Warfarin
- INR and interaction monitoring
- DOAC
- Renal function affects dosing
- Insulin
- Hypoglycemia risk
- Sulfonylurea
- Hypoglycemia risk
- Metformin
- Renal function limits use
- Aminoglycoside
- Nephrotoxicity and ototoxicity
- Lithium
- Monitor level, renal, thyroid
- Chronic corticosteroid
- Do not stop abruptly
- Antimicrobial choice
- Site, culture, allergy, renal
Common Traps
Invented Blueprint Weights
DHA lists 14 areas ≠ DHA publishes no percentages
Wrong Pharmacist Code
PHO5481 is Pharmacist ≠ PHO5482 is Clinical Pharmacy
Score Report Assumption
Result is Pass/Fail ≠ Numeric score is withheld
Registration Confusion
Registration confirms eligibility ≠ Active license permits practice
Attempt Rule Confusion
Maximum three across authorities ≠ No DHA retake grace period
Strength Conversion Error
1% w/v = 10 mg/mL ≠ Convert units before calculating
Unsafe Decimal
Use leading zero ≠ Never use trailing zero
Modified-Release Damage
Do not crush routinely ≠ Verify product instructions
Glove Substitution
Gloves reduce exposure ≠ Hand hygiene remains required
Natural Means Safe
Supplements cause interactions ≠ Always collect supplement history
Allergy Mislabeling
Allergy is immune-mediated ≠ Side effect may be predictable
Antidote-Only Thinking
ABCs come first ≠ Supportive care remains essential
Last Minute
- 1.PHO5481 = DHA Pharmacist
- 2.PHO5482 = Clinical Pharmacy
- 3.150 questions in 3 hours
- 4.PHO5481 pass score is 60%
- 5.Assessment fee is USD 240
- 6.Official coverage has 14 areas
- 7.Domain weights are not published
- 8.Results report Pass/Fail only
- 9.Three attempts across UAE authorities
- 10.No DHA retake grace period
- 11.Registration is not active licensure
- 12.Facility activates professional license
- 13.C1V1 equals C2V2 for dilutions
- 14.Loading dose follows Vd
- 15.Maintenance dose follows clearance
- 16.Steady state needs several half-lives
- 17.Always align calculation units
- 18.Use leading, never trailing zeros
- 19.Gloves never replace hand hygiene
- 20.One syringe serves one patient
- 21.Check renal function before dosing
- 22.Natural products still interact
- 23.OTC red flags require referral
- 24.Poisoning starts with ABCs
- 25.Controlled medicines need stricter records
- 26.Follow current local clinical protocols
Explore More Gulf Pharmacist Licensing Exams
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.